News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trevena, Inc. Enters Research Collaboration with Merck & Co., Inc. (MRK) To Identify Novel Biased Ligand Molecules


5/2/2012 10:26:53 AM

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc., the leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a research collaboration with Merck, through a subsidiary. The collaboration will focus on screening for biased ligands against an undisclosed receptor using Trevena’s proprietary assays and know-how. Financial details of the collaboration have not been disclosed.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES